Tobramycin: in vitro activity and comparison with kanamycin and gentamicin
about
Tobramycin nephrotoxicity. A prospective clinical studyClinical study of the use of the new aminoglycoside tobramycin for therapy of infections due to gram-negative bacteria.Pharmacokinetics of tobramycin in patients with stable renal impairment, patients undergoing peritoneal dialysis, and patients on chronic hemodialysis.Tobramycin in bronchial secretionsTobramycin concentrations during peritoneal dialysisComparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosaTransferrable resistance to tobramycin in Klebsiella pneumoniae and Enterobacter cloacae associated with enzymatic acetylation of tobramycin.Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.In vitro activity of tobramycin and gentamicin.In vitro bactericidal effectiveness of four aminoglycoside antibioticsTobramycin and gentamicin concentrations in the serum of normal and anephric patients.Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.Evaluation of three antibiotic programs in newborn infants.In vitro sensitivity of isolates of Pseudomonas aeruginosa to carbenicillin, gentamicin, tobramycin, and some other antibiotics.
P2860
Q28328829-F4B1B6E0-8880-49BB-B84D-EB02B7C5D286Q34894851-E1FD26AE-23AF-4633-811E-93E9BFE40EF4Q34909845-CE864FD8-9CAA-4AF6-AEB7-4CBCF48C9A48Q35652722-EB4F3538-A5B3-4923-85DB-D0E470A98E49Q35653708-F971DC1D-BFD8-4202-89C9-C9B674FEF7E7Q35657703-E77F83A3-5D69-49D5-BEEF-539BB9E3772AQ35658162-A6ED5729-A259-4DB8-BCB7-A9AF7B86525CQ40942941-E9B6C600-5F2E-4CE4-A138-1F58349D24D5Q40946281-9B3AA58A-A554-48E8-B5BF-DBA4D3FA741CQ41028195-67F2F569-DBFC-41DB-B1F0-E75EB24CA55BQ41028668-6D2DEB0E-39EA-4A80-99FC-F4F74641A861Q41028709-14DC20AE-F6A3-43F0-8FBC-EDDA546884D4Q41029826-4D3BC2EC-C779-4DA7-A7FD-DA5E66415114Q42148113-3AF94B48-A6CD-4F40-8A81-69EBE6AE6F6DQ42928896-21D39BF2-5B3D-419B-B542-AAE632751756Q53956607-B7A89C63-BB0B-4B7B-9795-773C7D05D2FB
P2860
Tobramycin: in vitro activity and comparison with kanamycin and gentamicin
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
1972年论文
@zh
1972年论文
@zh-cn
name
Tobramycin: in vitro activity and comparison with kanamycin and gentamicin
@en
type
label
Tobramycin: in vitro activity and comparison with kanamycin and gentamicin
@en
prefLabel
Tobramycin: in vitro activity and comparison with kanamycin and gentamicin
@en
P2860
P356
P1476
Tobramycin: in vitro activity and comparison with kanamycin and gentamicin
@en
P2093
Del Bene VE
Farrar WE Jr
P2860
P304
P356
10.1128/AAC.1.4.340
P407
P577
1972-04-01T00:00:00Z